Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infection: How should classic Whipple disease be managed?

Literature DB >> 20442732

Infection: How should classic Whipple disease be managed?

Florence Fenollar, Didier Raoult.

Abstract

Mesh：

Substances：

Year: 2010 PMID： 20442732 DOI： 10.1038/nrgastro.2010.46

Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802

× No keyword cloud information.

11 in total

1. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations.

Authors: René Mahnel; Anja Kalt; Sabine Ring; Andreas Stallmach; Warren Strober; Thomas Marth
Journal: Am J Gastroenterol Date: 2005-05 Impact factor: 10.864

Review 2. Whipple's disease.

Authors: Florence Fenollar; Xavier Puéchal; Didier Raoult
Journal: N Engl J Med Date: 2007-01-04 Impact factor: 91.245

3. Comment on: therapy for Whipple's disease.

Authors: Nawal Bakkali; Florence Fenollar; Jean-Marc Rolain; Didier Raoult
Journal: J Antimicrob Chemother Date: 2008-02-05 Impact factor: 5.790

4. IV or not IV? Just one of the antibiotic questions in Whipple's disease.

Authors: Cynthia L Sears; Sara E Cosgrove
Journal: Gastroenterology Date: 2009-12-22 Impact factor: 22.682

5. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide.

Authors: Jean-Christophe Lagier; Florence Fenollar; Hubert Lepidi; Eric Liozon; Didier Raoult
Journal: J Infect Date: 2009-10-21 Impact factor: 6.072

6. Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients.

Authors: R D Keinath; D E Merrell; R Vlietstra; W O Dobbins
Journal: Gastroenterology Date: 1985-06 Impact factor: 22.682

7. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease.

Authors: Gerhard E Feurle; Natascha S Junga; Thomas Marth
Journal: Gastroenterology Date: 2009-10-29 Impact factor: 22.682

8. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei.

Authors: Florence Fenollar; Jean-Marc Rolain; Laurent Alric; Thomas Papo; Marie-Paule Chauveheid; Diederik van de Beek; Didier Raoult
Journal: Int J Antimicrob Agents Date: 2009-04-05 Impact factor: 5.283

9. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.

Authors: Nawal Bakkali; Florence Fenollar; Silpak Biswas; Jean-Marc Rolain; Didier Raoult
Journal: J Infect Dis Date: 2008-07-01 Impact factor: 5.226

10. Whipple's disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens.

Authors: Hubert Lepidi; Florence Fenollar; Rene Gerolami; Jean-Louis Mege; Marie-France Bonzi; Marc Chappuis; José Sahel; Didier Raoult
Journal: Hum Pathol Date: 2003-06 Impact factor: 3.466

5 in total

Review 1. Macrophage-related diseases of the gut: a pathologist's perspective.

Authors: Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal: Virchows Arch Date: 2012-05-11 Impact factor: 4.064

Review 2. Whipple's disease.

Authors: Federico Biagi; Lucia Trotta; Gino R Corazza
Journal: Intern Emerg Med Date: 2012-10 Impact factor: 3.397

Infection: How should classic Whipple disease be managed?

1. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations.

Review 2. Whipple's disease.

3. Comment on: therapy for Whipple's disease.

4. IV or not IV? Just one of the antibiotic questions in Whipple's disease.

5. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide.

6. Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients.

7. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease.

8. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei.

9. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.

10. Whipple's disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens.

Review 1. Macrophage-related diseases of the gut: a pathologist's perspective.

Review 2. Whipple's disease.

Review 3. Abdominal manifestations of histiocytic disorders in adults: imaging perspective.

Review 4. Diarrhoea due to small bowel diseases.

5. Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis.